Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$7.22 - $10.59 $229,480 - $336,592
-31,784 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$9.53 - $11.77 $22,948 - $28,342
-2,408 Reduced 7.04%
31,784 $306,000
Q1 2021

May 13, 2021

SELL
$10.1 - $12.74 $910,313 - $1.15 Million
-90,130 Reduced 72.5%
34,192 $359,000
Q4 2020

Feb 17, 2021

BUY
$8.63 - $11.22 $480,276 - $624,415
55,652 Added 81.04%
124,322 $1.38 Million
Q3 2020

Nov 13, 2020

BUY
$8.7 - $11.05 $90,984 - $115,560
10,458 Added 17.97%
68,670 $653,000
Q2 2020

Aug 13, 2020

SELL
$9.04 - $11.57 $575,884 - $737,055
-63,704 Reduced 52.25%
58,212 $544,000
Q1 2020

May 13, 2020

SELL
$8.66 - $12.13 $845,276 - $1.18 Million
-97,607 Reduced 44.46%
121,916 $1.3 Million
Q4 2019

Feb 14, 2020

BUY
$11.07 - $12.73 $2.43 Million - $2.79 Million
219,523 New
219,523 $2.68 Million

Others Institutions Holding SPOK

About Spok Holdings, Inc


  • Ticker SPOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 19,703,800
  • Market Cap $327M
  • Description
  • Spok Holdings, Inc., through its subsidiary, Spok, Inc., provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. It delivers clinical information to care teams when and where it matters to enhance patient outcomes. The company offers subscriptions to one-way or two-way messaging ser...
More about SPOK
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.